Novel cytokine peptide-based vaccines: An interleukin-4 vaccine suppresses airway allergic responses in mice

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 62, Issue 6, 2007, Pages 675-682

  Ma, Y ^a,b   Hayglass, K T ^a   Becker, A B ^a,b   Halayko, A J ^a,b   Basu, S ^a,b   Simons, F E R ^a   Peng, Z ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MANITOBA INSTITUTE OF CHILD HEALTH   (Canada)

Author keywords

Allergy; Hepatitis B core antigen; Immunotherapy; Interleukin 4; Vaccine

Indexed keywords

HEPATITIS B CORE ANTIGEN ASPARTYLLYSYLASPARAGINYLHISTIDYLLEUCYLARGINYLGLUTAMINYLISOLEUCYLISOLEUCYL GLYCYLISOLEUCYLLEUCYLASPARAGINYLGLUTAMIC ACID; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; METHACHOLINE; UNCLASSIFIED DRUG; VACCINE;

ACTIVE IMMUNIZATION; ALLERGIC ASTHMA; ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CELL HYPERPLASIA; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG POTENCY; EOSINOPHIL; FEMALE; GENETIC ENGINEERING; GOBLET CELL; HISTOLOGY; IMMUNOPATHOGENESIS; INFLAMMATION; INFLAMMATORY CELL; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROVOCATION TEST; VACCINE PRODUCTION; VIRUS LIKE AGENT; WESTERN BLOTTING;

ANIMALS; ASTHMA; AUTOANTIBODIES; BLOTTING, WESTERN; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ENGINEERING; HEPATITIS B CORE ANTIGENS; IMMUNOGLOBULIN G; IMMUNOTHERAPY; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; PEPTIDES; VACCINES, SYNTHETIC;

EID: 34248569682     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2007.01384.x     Document Type: Article

References (35)

1. Liossis SN, Tsokos GC. Monoclonal antibodies and fusion proteins in medicine. J Allergy Clin Immunol 2005 116 : 721 729 Quiz 730.
2. Prete M, Perosa F, Favoino E, Dammacco F. Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease. Clin Exp Med 2005 5 : 141 160.
3. Holgate ST, Chuchalin AG, Hebert J, Lotvall J, Persson GB, Chung KF et al. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy 2004 34 : 632 638.
4. Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006 367 : 29 35.
5. Sandborn WJ. New concepts in anti-tumor necrosis factor therapy for inflammatory bowel disease. Rev Gastroenterol Disord 2005 5 : 10 18.
6. Humbert M, Durham SR, Ying S, Kimmitt P, Barkans J, Assoufi B et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 1996 154 : 1497 1504.
7. Ying S, Humbert M, Barkans J, Corrigan CJ, Pfister R, Menz G et al. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1997 158 : 3539 3544.
8. Kabesch M, Schedel M, Carr D, Woitsch B, Fritzsch C, Weiland SK et al. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol 2006 117 : 269 274.
9. Hytonen AM, Lowhagen O, Arvidsson M, Balder B, Bjork AL, Lindgren S et al. Haplotypes of the interleukin-4 receptor alpha chain gene associate with susceptibility to and severity of atopic asthma. Clin Exp Allergy 2004 34 : 1570 1575.
10. Shi HZ, Deng JM, Xu H, Nong ZX, Xiao CQ, Liu ZM et al. Effect of inhaled interleukin-4 on airway hyperreactivity in asthmatics. Am J Respir Crit Care Med 1998 157 : 1818 1821.
11. Steinke JW. Anti-interleukin-4 therapy. Immunol Allergy Clin North Am 2004 24 : 599 614 vi.
12. Perkins C, Wills-Karp M, Finkelman FD. IL-4 induces IL-13-independent allergic airway inflammation. J Allergy Clin Immunol 2006 118 : 410 419.
13. Henderson WR Jr., Chi EY, Maliszewski CR. Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma. J Immunol 2000 164 : 1086 1095.
14. Kolaskar AS, Tongaonkar PC. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 1990 276 : 172 174.
15. Hopp TP, Woods KR. A computer program for predicting protein antigenic determinants. Mol Immunol 1983 20 : 483 489.
16. Wang H, Mao X, Simons FER, Peng Z. Induction of IgE responses using a recombinant mosquito salivary allergen rAed a 2 without adjuvant in mice. Int Arch Allergy Immunol 1999 120 : 135 140.
17. Ford JG, Rennick D, Donaldson DD, Venkayya R, McArthur C, Hansell E et al. IL-13 and IFN-gamma: interactions in lung inflammation. J Immunol 2001 167 : 1769 1777.
18. Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997 156 : 766 775.
19. Eisenbarth SC, PIgG2aott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002 196 : 1645 1651.
20. Gringeri A, Musicco M, Hermans P, Bentwich Z, Cusini M, Bergamasco A et al. Active anti-interferon-alpha immunization: a European-Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1-infected patients (the EURIS study). J Acquir Immune Defic Syndr Hum Retrovirol 1999 20 : 358 370.
21. Gonzalez G, Crombet T, Catala M, Mirabal V, Hernandez JC, Gonzalez Y et al. A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial. Ann Oncol 1998 9 : 431 435.
22. Rohn TA, Jennings GT, Hernandez M, Grest P, Beck M, Zou Y et al. Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur J Immunol 2006 36 : 2857 2867.
23. Uyttenhove C, Arendse B, Stroobant V, Brombacher F, Van Snick J. Development of an anti-IL-12 p40 auto-vaccine: protection in experimental autoimmune encephalomyelitis at the expense of increased sensitivity to infection. Eur J Immunol 2004 34 : 3572 3581.
24. Uyttenhove C, Van Snick J. Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur J Immunol 2006 36 : 2868 2874.
25. Chackerian B, Lenz P, Lowy DR, Schiller JT. Determinants of autoantibody induction by conjugated papillomavirus virus-like particles. J Immunol 2002 169 : 6120 6126.
26. Pumpens P, Grens E. HBV core particles as a carrier for B cell/T cell epitopes. Intervirology 2001 44 : 98 114.
27. Milich DR, Chen M, Schodel F, Peterson DL, Jones JE, Hughes JL. Role of B cells in antigen presentation of the hepatitis B core. Proc Natl Acad Sci U S A 1997 94 : 14648 14653.
28. Oliveira GA, Wetzel K, Calvo-Calle JM, Nussenzweig R, Schmidt A, Birkett A et al. Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial. Infect Immun 2005 73 : 3587 3597.
29. Beck LA, Marcotte GV, MacGlashan D, Togias A, Saini S. Omalizumab-induced reductions in mast cell Fce psilon RI expression and function. J Allergy Clin Immunol 2004 114 : 527 530.
30. Prussin C, Griffith DT, Boesel KM, Lin H, Foster B, Casale TB. Omalizumab treatment downregulates dendritic cell FcepsilonRI expression. J Allergy Clin Immunol 2003 112 : 1147 1154.
31. Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE et al. A critical role for eosinophils in allergic airways remodeling. Science 2004 305 : 1776 1779.
32. Lee JJ, Dimina D, Macias MP, Ochkur SI, McGarry MP, O'Neill KR et al. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 2004 305 : 1773 1776.
33. Dabbagh K, Takeyama K, Lee HM, Ueki IF, Lausier JA, Nadel JA. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol 1999 162 : 6233 6237.
34. Venkayya R, Lam M, Willkom M, Grunig G, Corry DB, Erle DJ. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol 2002 26 : 202 208.
35. Zagury D, Le Buanec H, Bizzini B, Burny A, Lewis G, Gallo RC. Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases. Cytokine Growth Factor Rev 2003 14 : 123 137.